APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotine Gums and Lozenges

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nicotine Gums and Lozenges Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026194 pages

Choose your research edition.

Industry ResearchNicotine Gums and Lozenges Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotine Gums and Lozenges Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nicotine Gums and Lozenges Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotine Gums and Lozenges Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotine Gums and Lozenges Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Nicotine Gums and Lozenges market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotine Gums and Lozenges include Novartis, Perrigo Company, Pfizer, Fertin Pharma, Johnson & Johnson, Cipla, Alkalon, GSK and Reynolds American, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicotine Gums and Lozenges market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotine Gums and Lozenges and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotine Gums and Lozenges sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotine Gums and Lozenges market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotine Gums and Lozenges Segment by Company

Novartis

Perrigo Company

Pfizer

Fertin Pharma

Johnson & Johnson

Cipla

Alkalon

GSK

Reynolds American

Dr. Reddy's Laboratories

Nicotine Gums and Lozenges Segment by Type

2 mg/piece

4 mg/piece

Other

Nicotine Gums and Lozenges Segment by Application

Withdrawal Clinics

Medical Practice

Individual Smokers

Others

Nicotine Gums and Lozenges Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotine Gums and Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotine Gums and Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotine Gums and Lozenges.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotine Gums and Lozenges market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicotine Gums and Lozenges manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nicotine Gums and Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nicotine Gums and Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nicotine Gums and Lozenges Industry Trends Table 2. Nicotine Gums and Lozenges Industry Drivers Table 3. Nicotine Gums and Lozenges Industry Opportunities and Challenges Table 4. Nicotine Gums and Lozenges Industry Restraints Table 5. Global Nicotine Gums and Lozenges Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nicotine Gums and Lozenges Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nicotine Gums and Lozenges Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Nicotine Gums and Lozenges Sales Market Share by Manufacturers Table 9. Global Nicotine Gums and Lozenges Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Nicotine Gums and Lozenges Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicotine Gums and Lozenges Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nicotine Gums and Lozenges Manufacturers, Product Type & Application Table 13. Global Nicotine Gums and Lozenges Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotine Gums and Lozenges by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2 mg/piece Table 17. Major Manufacturers of 4 mg/piece Table 18. Major Manufacturers of Other Table 19. Global Nicotine Gums and Lozenges Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Nicotine Gums and Lozenges Sales by Type (2021-2026) & (k units) Table 21. Global Nicotine Gums and Lozenges Sales by Type (2027-2032) & (k units) Table 22. Global Nicotine Gums and Lozenges Sales Market Share by Type (2021-2026) Table 23. Global Nicotine Gums and Lozenges Sales Market Share by Type (2027-2032) Table 24. Global Nicotine Gums and Lozenges Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Nicotine Gums and Lozenges Revenue by Type (2021-2026) & (k units) Table 26. Global Nicotine Gums and Lozenges Revenue by Type (2027-2032) & (k units) Table 27. Global Nicotine Gums and Lozenges Revenue Market Share by Type (2021-2026) Table 28. Global Nicotine Gums and Lozenges Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Withdrawal Clinics Table 30. Major Manufacturers of Medical Practice Table 31. Major Manufacturers of Individual Smokers Table 32. Major Manufacturers of Others Table 33. Global Nicotine Gums and Lozenges Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Nicotine Gums and Lozenges Sales by Application (2021-2026) & (k units) Table 35. Global Nicotine Gums and Lozenges Sales by Application (2027-2032) & (k units) Table 36. Global Nicotine Gums and Lozenges Sales Market Share by Application (2021-2026) Table 37. Global Nicotine Gums and Lozenges Sales Market Share by Application (2027-2032) Table 38. Global Nicotine Gums and Lozenges Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Nicotine Gums and Lozenges Revenue by Application (2021-2026) & (k units) Table 40. Global Nicotine Gums and Lozenges Revenue by Application (2027-2032) & (k units) Table 41. Global Nicotine Gums and Lozenges Revenue Market Share by Application (2021-2026) Table 42. Global Nicotine Gums and Lozenges Revenue Market Share by Application (2027-2032) Table 43. Global Nicotine Gums and Lozenges Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Nicotine Gums and Lozenges Sales by Region (2021-2026) & (k units) Table 45. Global Nicotine Gums and Lozenges Sales Market Share by Region (2021-2026) Table 46. Global Nicotine Gums and Lozenges Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Nicotine Gums and Lozenges Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Nicotine Gums and Lozenges Sales by Country (2021-2026) & (k units) Table 50. North America Nicotine Gums and Lozenges Sales by Country (2027-2032) & (k units) Table 51. Europe Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Nicotine Gums and Lozenges Sales by Country (2021-2026) & (k units) Table 53. Europe Nicotine Gums and Lozenges Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Nicotine Gums and Lozenges Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Nicotine Gums and Lozenges Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Nicotine Gums and Lozenges Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Nicotine Gums and Lozenges Sales by Country (2027-2032) & (k units) Table 60. Global Nicotine Gums and Lozenges Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Nicotine Gums and Lozenges Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Nicotine Gums and Lozenges Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Nicotine Gums and Lozenges Revenue Market Share by Region (2021-2026) Table 64. Global Nicotine Gums and Lozenges Revenue Market Share by Region (2027-2032) Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novartis Nicotine Gums and Lozenges Product Portfolio Table 69. Novartis Recent Development Table 70. Perrigo Company Company Information Table 71. Perrigo Company Business Overview Table 72. Perrigo Company Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Perrigo Company Nicotine Gums and Lozenges Product Portfolio Table 74. Perrigo Company Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Nicotine Gums and Lozenges Product Portfolio Table 79. Pfizer Recent Development Table 80. Fertin Pharma Company Information Table 81. Fertin Pharma Business Overview Table 82. Fertin Pharma Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Fertin Pharma Nicotine Gums and Lozenges Product Portfolio Table 84. Fertin Pharma Recent Development Table 85. Johnson & Johnson Company Information Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Johnson & Johnson Nicotine Gums and Lozenges Product Portfolio Table 89. Johnson & Johnson Recent Development Table 90. Cipla Company Information Table 91. Cipla Business Overview Table 92. Cipla Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Cipla Nicotine Gums and Lozenges Product Portfolio Table 94. Cipla Recent Development Table 95. Alkalon Company Information Table 96. Alkalon Business Overview Table 97. Alkalon Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Alkalon Nicotine Gums and Lozenges Product Portfolio Table 99. Alkalon Recent Development Table 100. GSK Company Information Table 101. GSK Business Overview Table 102. GSK Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. GSK Nicotine Gums and Lozenges Product Portfolio Table 104. GSK Recent Development Table 105. Reynolds American Company Information Table 106. Reynolds American Business Overview Table 107. Reynolds American Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Reynolds American Nicotine Gums and Lozenges Product Portfolio Table 109. Reynolds American Recent Development Table 110. Dr. Reddy's Laboratories Company Information Table 111. Dr. Reddy's Laboratories Business Overview Table 112. Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolio Table 114. Dr. Reddy's Laboratories Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Nicotine Gums and Lozenges Distributors List Table 118. Nicotine Gums and Lozenges Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Nicotine Gums and Lozenges Product Image Figure 2. Global Nicotine Gums and Lozenges Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotine Gums and Lozenges Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicotine Gums and Lozenges Sales (2021-2032) & (k units) Figure 5. Global Nicotine Gums and Lozenges Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nicotine Gums and Lozenges Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2 mg/piece Image Figure 9. 4 mg/piece Image Figure 10. Other Image Figure 11. Global Nicotine Gums and Lozenges Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Nicotine Gums and Lozenges Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotine Gums and Lozenges Sales Market Share by Type (2021-2032) Figure 14. Global Nicotine Gums and Lozenges Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Nicotine Gums and Lozenges Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotine Gums and Lozenges Revenue Market Share by Type (2021-2032) Figure 17. Withdrawal Clinics Image Figure 18. Medical Practice Image Figure 19. Individual Smokers Image Figure 20. Others Image Figure 21. Global Nicotine Gums and Lozenges Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Nicotine Gums and Lozenges Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Nicotine Gums and Lozenges Sales Market Share by Application (2021-2032) Figure 24. Global Nicotine Gums and Lozenges Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Nicotine Gums and Lozenges Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Nicotine Gums and Lozenges Revenue Market Share by Application (2021-2032) Figure 27. North America Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Nicotine Gums and Lozenges Sales Market Share by Country (2021-2032) Figure 29. U.S. Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Nicotine Gums and Lozenges Sales Market Share by Country (2021-2032) Figure 34. Germany Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Nicotine Gums and Lozenges Sales Market Share by Country (2021-2032) Figure 41. China Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Nicotine Gums and Lozenges Sales Market Share by Country (2021-2032) Figure 49. Brazil Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Nicotine Gums and Lozenges Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Nicotine Gums and Lozenges Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Nicotine Gums and Lozenges Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Nicotine Gums and Lozenges Revenue (2021-2032) & (US$ Million) Figure 60. North America Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Nicotine Gums and Lozenges Revenue (2021-2032) & (US$ Million) Figure 62. Europe Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Nicotine Gums and Lozenges Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Nicotine Gums and Lozenges Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nicotine Gums and Lozenges Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Nicotine Gums and Lozenges Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2 mg/piece
  • 4 mg/piece
  • Other
Applications
  • Withdrawal Clinics
  • Medical Practice
  • Individual Smokers
  • Others
Companies covered
  • Novartis
  • Perrigo Company
  • Pfizer
  • Fertin Pharma
  • Johnson & Johnson
  • Cipla
  • Alkalon
  • GSK
  • Reynolds American
  • Dr. Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nicotine Gums and Lozenges Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nicotine Gums and Lozenges Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nicotine Gums and Lozenges Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nicotine Gums and Lozenges Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nicotine Gums and Lozenges Market Dynamics
  1. 2.1 Nicotine Gums and Lozenges Industry Trends
  2. 2.2 Nicotine Gums and Lozenges Industry Drivers
  3. 2.3 Nicotine Gums and Lozenges Industry Opportunities and Challenges
  4. 2.4 Nicotine Gums and Lozenges Industry Restraints
3 Nicotine Gums and Lozenges Market by Manufacturers
  1. 3.1 Global Nicotine Gums and Lozenges Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nicotine Gums and Lozenges Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nicotine Gums and Lozenges Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicotine Gums and Lozenges Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotine Gums and Lozenges Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nicotine Gums and Lozenges Manufacturers, Product Type & Application
  7. 3.7 Global Nicotine Gums and Lozenges Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotine Gums and Lozenges Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotine Gums and Lozenges Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicotine Gums and Lozenges Tier 1, Tier 2, and Tier 3
4 Nicotine Gums and Lozenges Market by Type
  1. 4.1 Nicotine Gums and Lozenges Type Introduction
  2. 4.1.1 2 mg/piece
  3. 4.1.2 4 mg/piece
  4. 4.1.3 Other
  5. 4.2 Global Nicotine Gums and Lozenges Sales by Type
  6. 4.2.1 Global Nicotine Gums and Lozenges Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nicotine Gums and Lozenges Sales by Type (2021-2032)
  8. 4.2.3 Global Nicotine Gums and Lozenges Sales Market Share by Type (2021-2032)
  9. 4.3 Global Nicotine Gums and Lozenges Revenue by Type
  10. 4.3.1 Global Nicotine Gums and Lozenges Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nicotine Gums and Lozenges Revenue by Type (2021-2032)
  12. 4.3.3 Global Nicotine Gums and Lozenges Revenue Market Share by Type (2021-2032)
5 Nicotine Gums and Lozenges Market by Application
  1. 5.1 Nicotine Gums and Lozenges Application Introduction
  2. 5.1.1 Withdrawal Clinics
  3. 5.1.2 Medical Practice
  4. 5.1.3 Individual Smokers
  5. 5.1.4 Others
  6. 5.2 Global Nicotine Gums and Lozenges Sales by Application
  7. 5.2.1 Global Nicotine Gums and Lozenges Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nicotine Gums and Lozenges Sales by Application (2021-2032)
  9. 5.2.3 Global Nicotine Gums and Lozenges Sales Market Share by Application (2021-2032)
  10. 5.3 Global Nicotine Gums and Lozenges Revenue by Application
  11. 5.3.1 Global Nicotine Gums and Lozenges Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nicotine Gums and Lozenges Revenue by Application (2021-2032)
  13. 5.3.3 Global Nicotine Gums and Lozenges Revenue Market Share by Application (2021-2032)
6 Global Nicotine Gums and Lozenges Sales by Region
  1. 6.1 Global Nicotine Gums and Lozenges Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotine Gums and Lozenges Sales by Region (2021-2032)
  3. 6.2.1 Global Nicotine Gums and Lozenges Sales by Region (2021-2026)
  4. 6.2.2 Global Nicotine Gums and Lozenges Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nicotine Gums and Lozenges Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nicotine Gums and Lozenges Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nicotine Gums and Lozenges Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nicotine Gums and Lozenges Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nicotine Gums and Lozenges Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nicotine Gums and Lozenges Revenue by Region
  1. 7.1 Global Nicotine Gums and Lozenges Revenue by Region
  2. 7.1.1 Global Nicotine Gums and Lozenges Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nicotine Gums and Lozenges Revenue by Region (2021-2026)
  4. 7.1.3 Global Nicotine Gums and Lozenges Revenue by Region (2027-2032)
  5. 7.1.4 Global Nicotine Gums and Lozenges Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nicotine Gums and Lozenges Revenue (2021-2032)
  8. 7.2.2 North America Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nicotine Gums and Lozenges Revenue (2021-2032)
  11. 7.3.2 Europe Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nicotine Gums and Lozenges Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nicotine Gums and Lozenges Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nicotine Gums and Lozenges Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Nicotine Gums and Lozenges Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Perrigo Company
  8. 8.2.1 Perrigo Company Company Information
  9. 8.2.2 Perrigo Company Business Overview
  10. 8.2.3 Perrigo Company Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Perrigo Company Nicotine Gums and Lozenges Product Portfolio
  12. 8.2.5 Perrigo Company Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Nicotine Gums and Lozenges Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Fertin Pharma
  20. 8.4.1 Fertin Pharma Company Information
  21. 8.4.2 Fertin Pharma Business Overview
  22. 8.4.3 Fertin Pharma Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fertin Pharma Nicotine Gums and Lozenges Product Portfolio
  24. 8.4.5 Fertin Pharma Recent Developments
  25. 8.5 Johnson & Johnson
  26. 8.5.1 Johnson & Johnson Company Information
  27. 8.5.2 Johnson & Johnson Business Overview
  28. 8.5.3 Johnson & Johnson Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Johnson & Johnson Nicotine Gums and Lozenges Product Portfolio
  30. 8.5.5 Johnson & Johnson Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Nicotine Gums and Lozenges Product Portfolio
  36. 8.6.5 Cipla Recent Developments
  37. 8.7 Alkalon
  38. 8.7.1 Alkalon Company Information
  39. 8.7.2 Alkalon Business Overview
  40. 8.7.3 Alkalon Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alkalon Nicotine Gums and Lozenges Product Portfolio
  42. 8.7.5 Alkalon Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Nicotine Gums and Lozenges Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Reynolds American
  50. 8.9.1 Reynolds American Company Information
  51. 8.9.2 Reynolds American Business Overview
  52. 8.9.3 Reynolds American Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reynolds American Nicotine Gums and Lozenges Product Portfolio
  54. 8.9.5 Reynolds American Recent Developments
  55. 8.10 Dr. Reddy's Laboratories
  56. 8.10.1 Dr. Reddy's Laboratories Company Information
  57. 8.10.2 Dr. Reddy's Laboratories Business Overview
  58. 8.10.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolio
  60. 8.10.5 Dr. Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotine Gums and Lozenges Value Chain Analysis
  2. 9.1.1 Nicotine Gums and Lozenges Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotine Gums and Lozenges Production Mode & Process
  6. 9.2 Nicotine Gums and Lozenges Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotine Gums and Lozenges Distributors
  9. 9.2.3 Nicotine Gums and Lozenges Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst